Ludwig Enterprises (LUDG) Income from Continuing Operations (2022 - 2026)
Ludwig Enterprises (LUDG) posted Income from Continuing Operations of 218847.0 for Q1 2026, up 120.31% on a QoQ basis from 1077298.0 in Q4 2025, and up 140.46% year-over-year from 91013.11 in Q1 2025.
Ludwig Enterprises (LUDG) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Ludwig Enterprises' Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 218847.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 140.46% year-over-year to 218847.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1476643.0 (up 26.69% YoY) and the FY2025 annual result came in at 2236433.0, up 26.71% from the prior year.
- Income from Continuing Operations was 218847.0 for Q1 2026 at Ludwig Enterprises, up from 1077298.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 218847.0 in Q1 2026 and bottomed at 1578344.0 in Q1 2024.
- A 5-year average of 551544.0 and a median of 562195.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 283.05% — and 2026, when it surged 140.46%.
- Ludwig Enterprises' Income from Continuing Operations stood at 681105.0 in 2022, then jumped by 45.43% to 371701.0 in 2023, then fell by 8.07% to 401704.0 in 2024, then tumbled by 168.18% to 1077298.0 in 2025, then surged by 120.31% to 218847.0 in 2026.
- Business Quant data shows LUDG's Income from Continuing Operations at 218847.0 in Q1 2026, 1077298.0 in Q4 2025, and 31252.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ludwig Enterprises | 3.27 Mn | 3.27 Mn | - | 218,847.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218,847.00 |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | 31,252.00 |
| Jun 30, 2025 | -649,444.00 |
| Mar 31, 2025 | -540,943.00 |
| Dec 31, 2024 | -401,704.00 |
| Sep 30, 2024 | -749,129.00 |
| Jun 30, 2024 | -322,510.00 |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | -371,701.00 |
| Sep 30, 2023 | -195,570.00 |
| Jun 30, 2023 | -583,447.00 |
| Mar 31, 2023 | -820,520.00 |
| Dec 31, 2022 | -681,105.00 |